Clinical Trial Update: Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study [NA]

View source ↗

Summary

This clinical trial update describes a longitudinal 7T MRI study investigating grey matter damage at the earliest stages of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Multiple Sclerosis | NA | Status: ACTIVE_NOT_RECRUITING